My patient sent me this today! I’m so grateful. 👏🏼Cheers to our patients and our MA state legislature #testicularcancer Christopher Sweeney, MBBS Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber News Movember USA Alok Tewari Dr. Darren Feldman Toni Choueiri, MD Tim Clinton

Congratulations to Dr. Reuter!

Read our March/April issue!

acsjournals.onlinelibrary.wiley.com/toc/15424863/2…

In this issue:
🔹 Moffitt Cancer Center researchers on a case of dMMR/MSI-H gastric cancer
🔹 2023 ACS Research report of #CancerDisparities in the US
🔹 Testicular cancer in 2023 by Dr. Darren Feldman Jack Gleeson et al

OncoAlert

Star UrologyMSK fellow Dr. Fady Baky presenting a poster on the MSK experience with our NYS DOH approved CLIA certified serum miRNA assay in stage I testis cancer showing high accuracy for predicting viable non-teratomatous GCT. Rich Matulewicz DrBagrodia

If you take care of testicular cancer patients (or want to in the future), not going to find a more comprehensive review than this......

Dr. Darren Feldman Jack Gleeson

Testicular cancer in 2023: Current status and recent progress acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

Right now, amazing clinician scientist, colleague and friend, Andrea Apollo, presenting positive results of the Alliance Ambassador Trial of adjuvant pembro vs observation following cystectomy in urothelial cancer. #GU24 Alliance for Clinical Trials in Oncology

This article reviews contemporary evidence-based treatments for extracranial testicular germ cell tumor, the acute and chronic toxic effects that may result, and highlights recent advances and progress in the field.

acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

Dr. Darren Feldman
Jack Gleeson

Joining the annual meeting of Malignant Germ Cell International Consortium in Edinburgh with interesting talks on #testis #cancer therapy and miRNA in vesicles by Dr. Darren Feldman and Matthew Murray, respectively…

Another exciting Plenary - Keynote Two. Chaired by 💉💉💉A/Prof. Haryana Dhillon💉💉💉 and Chun Loo Gan, this session features international speakers Andrea Apolo, M.D. Dr. Darren Feldman Alex Wyatt and Ananya Choudhury. Get ready for inspiring insights and thought-provoking discussions! #ANZUP23 #Plenary

#ANZUP23 trials meeting off to a great start welcoming international superstars Andrea Apolo, M.D. Dr. Darren Feldman Sima Porten Alex Wyatt, Ananya Choudhury with Ben Tran Ian Davis Renu Eapen

ASCO #ASCO23 Great opportunity to meet colleagues I know only from Twitter & catch up with friends! ❤️Stacy Loeb, MD Cora Sternberg Shuchi Gulati MD KSridhar Shilpa Gupta Gil Morgan, MD OncoAlert Dr. Darren Feldman Sumanta K. Pal, MD, FASCO Suzanne Cole, MD Elizabeth Plimack MD KMittaloncMD Petros Grivas Toni Choueiri, MD

Sam Funt from ⁦Memorial Sloan Kettering Cancer Center⁩ describes an IO/IO study in refractory #germcell tumors. Minimal activity and novel mechanisms are needed. ⁦Dr. Darren Feldman⁩

Dr. Bajorin has been a transformative figure in oncology training, and I continue to learn from him every day. I am grateful to be able to have him as a colleague, mentor, and friend.

Congratulations Sumanta K. Pal, MD, FASCO on being elected to the ASCO nominating committee!

The TIGER trial has officially reached our target accrual! Thanks to all investigators, Alliance for Clinical Trials in Oncology, EORTC, ANZUP, Movember USA, and most of all to patients and their families. Uromigos Tom Powles silke gillessen Michael Morris, Robert Motzer MD Jonathan Rosenberg MD

Enfortumab vedotin + pembrolizumab shrank locally advanced and metastatic #BladderCancer tumors in 64.5% of patients (⬆️ than standard treatments); and 15.6% saw tumors disappear completely, Jonathan Rosenberg MD reported at #ESMO22 . bit.ly/3DggdLR

To investigators of the TIGER study: Only 25 patients missing to complete enrolment. Thanks for all the efforts until now and please help to finish the study ideally this year! Tom Powles Dr. Darren Feldman EORTC Alliance for Clinical Trials in Oncology Uromigos ANZUP OncoAlert

Cabozantinib plus Nivolumab shows a 48% objective response rate in a phase II study in non-clear cell RCC. Journal of Clinical Oncology Robert Motzer MD Memorial Sloan Kettering Cancer Center ascopubs.org/doi/abs/10.120…

We see you. We really, really see you. 💙💛

The top abstracts are the height of new devs in #kidneycancer . Join us now to discuss the future of treatment and care with Dr. Darren Feldman Dr. Sunil Sudarshan feat. Pedro C Barata, MD MSc FACP Sari Khaleel Dr. Charlotte Spencer, Dr. Nizar Tannir, Akash Kaushik #IKCS2021